412 related articles for article (PubMed ID: 35411434)
1. Cellular Conversations in Glioblastoma Progression, Diagnosis and Treatment.
Sisakht AK; Malekan M; Ghobadinezhad F; Firouzabadi SNM; Jafari A; Mirazimi SMA; Abadi B; Shafabakhsh R; Mirzaei H
Cell Mol Neurobiol; 2023 Mar; 43(2):585-603. PubMed ID: 35411434
[TBL] [Abstract][Full Text] [Related]
2. [Dynamic trajectory and cell communication of different cell clusters in malignant progression of glioblastoma].
Cai X; Wang R; Wang S; Ren Z; Yu Q; Li D
Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 56(2):199-206. PubMed ID: 38595234
[TBL] [Abstract][Full Text] [Related]
3. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma.
Pachocki CJ; Hol EM
J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059
[TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities.
Wang G; Zhong K; Wang Z; Zhang Z; Tang X; Tong A; Zhou L
Front Immunol; 2022; 13():964898. PubMed ID: 35967394
[TBL] [Abstract][Full Text] [Related]
6. Spatial Heterogeneity of Invading Glioblastoma Cells Regulated by Paracrine Factors.
Chonan Y; Yamashita T; Sampetrean O; Saya H; Sudo R
Tissue Eng Part A; 2022 Jul; 28(13-14):573-585. PubMed ID: 34841881
[TBL] [Abstract][Full Text] [Related]
7. Glioma: molecular signature and crossroads with tumor microenvironment.
Barthel L; Hadamitzky M; Dammann P; Schedlowski M; Sure U; Thakur BK; Hetze S
Cancer Metastasis Rev; 2022 Mar; 41(1):53-75. PubMed ID: 34687436
[TBL] [Abstract][Full Text] [Related]
8. Extracellular lipid loading augments hypoxic paracrine signaling and promotes glioma angiogenesis and macrophage infiltration.
Offer S; Menard JA; Pérez JE; de Oliveira KG; Indira Chandran V; Johansson MC; Bång-Rudenstam A; Siesjö P; Ebbesson A; Hedenfalk I; Sundgren PC; Darabi A; Belting M
J Exp Clin Cancer Res; 2019 Jun; 38(1):241. PubMed ID: 31174567
[TBL] [Abstract][Full Text] [Related]
9. Glioblastoma microenvironment: The stromal interactions.
Uyar R
Pathol Res Pract; 2022 Apr; 232():153813. PubMed ID: 35228161
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles in the glioblastoma microenvironment: A diagnostic and therapeutic perspective.
Russo MN; Whaley LA; Norton ES; Zarco N; Guerrero-Cázares H
Mol Aspects Med; 2023 Jun; 91():101167. PubMed ID: 36577547
[TBL] [Abstract][Full Text] [Related]
11. Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration.
Uneda A; Kurozumi K; Fujimura A; Fujii K; Ishida J; Shimazu Y; Otani Y; Tomita Y; Hattori Y; Matsumoto Y; Tsuboi N; Makino K; Hirano S; Kamiya A; Date I
Acta Neuropathol Commun; 2021 Feb; 9(1):29. PubMed ID: 33618763
[TBL] [Abstract][Full Text] [Related]
12. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
13. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
[TBL] [Abstract][Full Text] [Related]
14. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.
Asija S; Chatterjee A; Yadav S; Chekuri G; Karulkar A; Jaiswal AK; Goda JS; Purwar R
Int Rev Immunol; 2022; 41(6):582-605. PubMed ID: 35938932
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma Microenvironment and Invasiveness: New Insights and Therapeutic Targets.
Erices JI; Bizama C; Niechi I; Uribe D; Rosales A; Fabres K; Navarro-Martínez G; Torres Á; San Martín R; Roa JC; Quezada-Monrás C
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108208
[TBL] [Abstract][Full Text] [Related]
17. Astrocytes, the rising stars of the glioblastoma microenvironment.
Brandao M; Simon T; Critchley G; Giamas G
Glia; 2019 May; 67(5):779-790. PubMed ID: 30240060
[TBL] [Abstract][Full Text] [Related]
18. Systematic Review on Tumor Microenvironment in Glial Neoplasm: From Understanding Pathogenesis to Future Therapeutic Perspectives.
Bianconi A; Aruta G; Rizzo F; Salvati LF; Zeppa P; Garbossa D; Cofano F
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456984
[TBL] [Abstract][Full Text] [Related]
19. The emergent role of exosomes in glioma.
Gourlay J; Morokoff AP; Luwor RB; Zhu HJ; Kaye AH; Stylli SS
J Clin Neurosci; 2017 Jan; 35():13-23. PubMed ID: 27771233
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment.
Hong S; You JY; Paek K; Park J; Kang SJ; Han EH; Choi N; Chung S; Rhee WJ; Kim JA
Theranostics; 2021; 11(19):9687-9704. PubMed ID: 34646393
[No Abstract] [Full Text] [Related]
[Next] [New Search]
